Evidence Synthesis
Omaxe Sees Continued Growth in Daily Trading Volume and Close Price, But Faces Challenges in Gross Margin.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 02:11
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Omaxe Sees Continued Growth in Daily Trading Volume and Close Price, But Faces Challenges in Gross Margin.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | -24.74 % | -0.14 | ▼ |
| MARGINAL_OPERATING_LEVERAGE | -0.14 % | -37.04 | ▲ |
| REVENUE_GROWTH_YOY | 43.9 % | — | - |
| PRICE_CHANGE_PERCENT | 7.141 % | — | - |
| DAILY_VOLUME | 56,01,567 shares | 42,44,943 | ▲ |
| CLOSE_PRICE | 136.38 INR | 127.29 | ▲ |